PRTN3 and rheumatoid arthritis: The ACPA-positive RA patients achieving SDFR (n = 15) had a median DAS4 months of 2.22 units (IQR, 2.19–2.37) with a median ΔDAS0–4m of − 0.60 units (IQR, − 0.96, − 0.50).